Cargando…
CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity
Donor T-cells contribute to reconstitution of protective immunity after allogeneic hematopoietic stem cell transplantation (HSCT) but must acquire specific tolerance against recipient alloantigens to avoid life-threatening graft-versus-host disease (GvHD). Systemic immunosuppressive drugs may abroga...
Autores principales: | Dillinger, Barbara, Ahmadi-Erber, Sarah, Soukup, Klara, Halfmann, Angela, Schrom, Silke, Vanhove, Bernard, Steinberger, Peter, Geyeregger, Rene, Ladisch, Stephan, Dohnal, Alexander Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611377/ https://www.ncbi.nlm.nih.gov/pubmed/28979262 http://dx.doi.org/10.3389/fimmu.2017.01152 |
Ejemplares similares
-
Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response
por: Soukup, Klara, et al.
Publicado: (2017) -
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
por: Davies, Jeff K., et al.
Publicado: (2011) -
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
Publicado: (1995) -
Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts
por: Zhu, Maoshu, et al.
Publicado: (2020) -
Correction: Thalidomide with blockade of costimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts
por: Zhu, Maoshu, et al.
Publicado: (2022)